Hydantoin derivatives for treating complications of diabetes
    9.
    发明授权
    Hydantoin derivatives for treating complications of diabetes 失效
    用于治疗糖尿病并发症的乙内酰脲衍生物

    公开(公告)号:US4985573A

    公开(公告)日:1991-01-15

    申请号:US355623

    申请日:1989-05-23

    摘要: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group, in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitrogen or oxygen atom, ##STR3## in which R.sub.3 and R.sub.4 are same or different independently and each is hydrogen atom or an alkyl group,X is oxygen or sulfur atom, and Y and Z are same or different independently and each is hydrogen atom, a halogen atom, alkyl group, alkoxy group, alkylmercapto group, nitro radical or --NHR.sub.5 group, in which R.sub.5 is hydrogen atom or an acyl group.The derivatives and salts thereof are useful for the treatment of complications of diabetes.

    摘要翻译: 乙内酰脲衍生物及其盐,其中间体,其制备方法和含有该衍生物的药物,其中所述衍生物具有式“IMAGE”,其中V和W之一是氢,另一个是卤代甲基,1H-四唑 - 其中R为氢原子,烷基, - (CH 2 CH 2 O)n CH 3基(n为1至113的整数)或取代的苯基,其中R 1和R 2相同的-COOR基团 或独立地不同,各自为氢原子,烷基,取代的苯基或 - (CH 2 CH 2 O)n CH 3基团(n具有所述的含义)或R 1可以与R 2和氮或氧原子一起形成杂环, 其中R3和R4独立地相同或不同,各自为氢原子或烷基,X为氧或硫原子,Y和Z独立地相同或不同,各自为氢原子,卤素原子,烷基,烷氧基 基团,烷基巯基,硝基或-NHR 5基团 ch R5是氢原子或酰基。 其衍生物和盐可​​用于治疗糖尿病并发症。